← Back
Data updated: Mar 10, 2026
HETERO LABS LTD III
CardiovascularInfectious DiseaseImmunology
HETERO LABS LTD III is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Immunology. Key products include ESOMEPRAZOLE MAGNESIUM.
2008
Since
65
Drugs
-
Trials
923
Approved (2yr)
Key Drugs
SACUBITRIL AND VALSARTAN
sacubitril
AT1 receptor 2 indications · 2024
DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE
dextromethorphan hydrobromide
NMDA receptor 1 indications · 2017
LOPINAVIR AND RITONAVIR
lopinavir
CYP3A 1 indications · 2016
LEVOCETIRIZINE HYDROCHLORIDE
levocetirizine dihydrochloride
1 indications · 2019
LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
lamivudine
· 2018
Recent Activity
PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
ARIPIPRAZOLE 2026-02-18
PREGABALIN 2026-02-03
Labeling
PREGABALIN 2026-02-02
Labeling
PREGABALIN 2026-02-02
Labeling
LACOSAMIDE 2026-01-29
FINASTERIDE 2026-01-26
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 32%
6 drugs
Infectious Disease 32%
6 drugs
Immunology 16%
3 drugs
Respiratory 11%
2 drugs
Gastroenterology 11%
2 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Infectious Disease, Immunology, Gastroenterology
Novartis big-pharma
Cardiovascular, Immunology, Respiratory
APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology, Respiratory
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
Gilead Sciences biotech
Infectious Disease, Immunology, Gastroenterology, Respiratory
Active (30)
SACUBITRIL AND VALSARTAN MARAVIROC VARENICLINE TARTRATE DABIGATRAN ETEXILATE MESYLATE POSACONAZOLE LEVOCETIRIZINE HYDROCHLORIDE ROFLUMILAST TADALAFIL TRIENTINE HYDROCHLORIDE DARUNAVIR DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE LOPINAVIR AND RITONAVIR OSELTAMIVIR PHOSPHATE RUFINAMIDE ARIPIPRAZOLE TENOFOVIR DISOPROXIL FUMARATE ESOMEPRAZOLE MAGNESIUM RITONAVIR RANOLAZINE ABACAVIR SULFATE LAMIVUDINE LEVOCETIRIZINE DIHYDROCHLORIDE LANSOPRAZOLE LEVETIRACETAM OXCARBAZEPINE SIMVASTATIN LORATADINE OMEPRAZOLE KETOROLAC TROMETHAMINE ACYCLOVIR
Discontinued (30)
PREGABALIN LACOSAMIDE FINASTERIDE FENOFIBRATE HYDROXYZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY FLUPHENAZINE HYDROCHLORIDE ESCITALOPRAM OXALATE LITHIUM CARBONATE NAPROXEN ZIDOVUDINE TOLTERODINE TARTRATE OMEPRAZOLE MAGNESIUM SPIRONOLACTONE EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE HYDRALAZINE HYDROCHLORIDE METOPROLOL SUCCINATE INDOMETHACIN NEVIRAPINE RALTEGRAVIR POTASSIUM METHOCARBAMOL DULOXETINE HYDROCHLORIDE CLOBAZAM DIMETHYL FUMARATE CITALOPRAM HYDROBROMIDE EZETIMIBE LAMIVUDINE AND ZIDOVUDINE TORSEMIDE ATOVAQUONE STAVUDINE
Company Info
- First Approval
- 2008-04-25
- Latest
- 2025-11-18
- Applications
- 79